AINEWS
Peptides are short amino acid drugs that have to be injected or nasally sprayed, and on the gray market, the reviews, the forums, and the "verified" badges all look AI generated.
A peptide is a short chain of amino acids, a few dozen residues long, that the stomach tears apart the way it tears apart any protein. That is why most peptide drugs arrive in a syringe or a nasal spray, and why the consumer market for them is a gray one: regulated in clinics, casually sold online. It is also why a recent walk through the gray market turned into a survey of broken trust infrastructure.
The first stop was Qingdao Sigma, a Chinese chemical supplier whose name comes up constantly in peptide forums. Its storefront looks normal, the products are cheap, the checkout takes a credit card. So does its "TrustPilot" page, except that page is not on TrustPilot. It sits on Qingdao Sigma's own domain, styled as the real thing, with no link back to a genuine TrustPilot listing. The author of a recent Substack analysis noticed one of the embedded reviews, written from "Germany," offering a sanity check on a Berlin trip; the writer happened to be in Berlin at the time, and the German review was not.
A few clicks away is CompoundTalk, an independent-looking peptide-supplier review site. The aesthetic is what the same writer calls "Claude Code's fingerprint": a generic modern layout, long-winded SEO copy about GLP-1 side effects, and body text set at 8 points. Some of the text on the review site is set at 8pt, small enough that most readers will not catch the dosage tables next to it. The site's "Verified Vendors" subforum is the load-bearing piece of the trust story: a list of supposedly vetted suppliers, with no visible verification trail, run on the same AI-fingerprinted template. The same observation surfaced in a Hacker News thread on the original post.
The receipts are anecdotal. The same shape is showing up in research-chemical storefronts, in software-key resellers, and in the telehealth-adjacent supplement shops that market themselves around GLP-1 agonists and BPC-157. What changed is the cost curve. A single agentic coding session can now produce a content-filled vendor site, a faux TrustPilot widget, and a faux independent review forum with a "Verified Vendors" subforum in an afternoon. The visible plumbing of online trust, from review widgets to "verified" badges to vetting threads, has stopped working in the niches where buyers are most exposed. The technique is portable because the templates are portable, and the platforms that used to flag the templates are slow to update.
Three portable tells. A review widget that lives on the vendor's own domain and does not link out to the real TrustPilot or Google profile is not a review; it is decoration. Second, body text set at 8 points, generic modern layouts, and long-winded SEO paragraphs about side effects are the surface marks of an AI-generated review site. Third, a "Verified Vendors" or "Vetted Suppliers" list with no visible verification trail is doing the opposite of what its name claims.
A buyer who got a vial of underdosed BPC-157 from a fake-vetted gray-market shop does not conclude that the gray market is corrupt. They conclude that peptides do not work. The scam market bleeds back into the regulated one as lost trust, which is the consequence the legitimate clinics do not yet have a way to measure.
The canary is peptides because the buyers are already buying blind; the next vertical will not warn the platforms first. The question is whether the trust platforms that are supposed to catch this are still catching it, or whether the niche has moved past them.